Source:http://linkedlifedata.com/resource/pubmed/id/21070502
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-11
|
pubmed:abstractText |
Twenty-five per cent of individuals infected with hepatitis C virus (HCV) are able to clear HCV spontaneously. Differences in host genetics are believed to affect the outcome of HCV infection. We analysed an exonic, a promoter and an intronic single nucleotide polymorphism (SNP) of the interferon-?3 coding interleukin (IL)-28B gene to study the relationship between IL28B SNPs and outcome of HCV infection. Among 206 HIV-1-infected Europeans with evidence of HCV infection, 47 (23%) individuals had cleared HCV and 159 (77%) had developed chronic infection. The exonic rs8103142 CT, the promoter rs12979860 CT and the intronic rs11881222 AG genotypes were associated with a decreased HCV clearance rate with adjusted odds ratios (aOR) of 0.3 (95% CI, 0.1-0.7), 0.4 (95% CI, 0.2-0.8) and 0.4 (95% CI, 0.2-0.8), respectively. The haplotype block TCG CTA was associated with a decreased HCV clearance rate (aOR 0.4, 95% CI, 0.2-0.8). Further, we found significant differences in HCV RNA levels among individuals chronically infected with HCV genotype 1 for rs8103142 and rs12979860 (P ? 0.05). Chronically infected individuals with HCV genotype 3 and with the favourable haplotype block CTA CTA had higher median HCV RNA levels than individuals with unfavourable haplotype blocks (P ? 0.05). Our findings suggest that IL28B may account for some differences in HCV outcome but that other factors including the viral genotype, host genetics and the host-virus interaction are likely to influence the outcome of HCV infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1365-2893
|
pubmed:author | |
pubmed:copyrightInfo |
© 2010 Blackwell Publishing Ltd.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e66-74
|
pubmed:meshHeading |
pubmed-meshheading:21070502-Adult,
pubmed-meshheading:21070502-Female,
pubmed-meshheading:21070502-Gene Frequency,
pubmed-meshheading:21070502-HIV Infections,
pubmed-meshheading:21070502-Haplotypes,
pubmed-meshheading:21070502-Hepacivirus,
pubmed-meshheading:21070502-Hepatitis C,
pubmed-meshheading:21070502-Humans,
pubmed-meshheading:21070502-Interleukins,
pubmed-meshheading:21070502-Male,
pubmed-meshheading:21070502-Polymorphism, Single Nucleotide,
pubmed-meshheading:21070502-Treatment Outcome,
pubmed-meshheading:21070502-Viral Load
|
pubmed:year |
2011
|
pubmed:articleTitle |
Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort.
|
pubmed:affiliation |
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark. louisenygaard@dadlnet.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|